Impact of the iCODEX tool in routine clinical practice in Spain.


Journal

Current medical research and opinion
ISSN: 1473-4877
Titre abrégé: Curr Med Res Opin
Pays: England
ID NLM: 0351014

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 14 12 2021
medline: 21 4 2022
entrez: 13 12 2021
Statut: ppublish

Résumé

The prognosis of COPD patients can be calculated using multidimensional indexes that improve the predictive capacity of the individual variables. The CODEX index can be calculated using iCODEX, a digital support tool available on the web and in an app. The aim of this study was to evaluate how the usefulness and applicability of iCODEX and its recommendations in routine clinical practice are perceived by specialists in internal medicine, pneumology, and primary care. A cross-sectional study was conducted from November 2019 to February 2020 with the participation of specialists in internal medicine, primary care, and pneumology. All respondents completed a survey consisting of 104 questions on their perception of the iCODEX tool. Overall, 335 physicians responded. Of these, 95.2% had no difficulty accessing the tool and 83.1% were quite or very satisfied with it. Regarding the applicability and implementation of iCODEX recommendations in routine clinical practice, respondents reported that the recommendations were generally applicable: most questions obtained a median score of ≥ 4 out of 5. The recommendations with the greatest expected clinical benefit are listed. Our study shows that the iCODEX tool is easy for participating specialists to use and identifies the recommendations that have the greatest clinical impact in areas such as lung obstruction, severe exacerbations, exercise, smoking, and patient follow-up.

Identifiants

pubmed: 34894948
doi: 10.1080/03007995.2021.2014162
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-187

Auteurs

María Gómez-Antúnez (M)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Jesús Recio-Iglesias (J)

Hospital Vithas 9 de octubre de Valencia, Valencia, Spain.

Pere Almagro (P)

Hospital Universitari Mútua de Terrassa, Barcelona, Terrassa, Spain.

Jesús Díez-Manglano (J)

Hospital Royo Villanova, Zaragoza, Spain.

Francisco López-García (F)

Hospital General de Elche, Alicante, Elche, Spain.

Ramon Boixeda (R)

Hospital de Mataró, Barcelona, Mataró, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH